Top Markets
Coin of the day
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
株式のランク #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
株価
$0.53499835
時価総額
$40.24M
変化(1日)
2.50%
変化(1年)
-58.07%
JP
取引 Chordia Therapeutics Inc. (190A)

カテゴリー

Chordia Therapeutics Inc.(190A)の株価履歴
終値の最高値: $0.53 (2026-08-01)

終値の最安値: $1.06 (2024-06-01)
Chordia Therapeutics Inc. の株価履歴(2024 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$546.54 38.59%
US
$1.04K 56.71%
NL
$120.74 -14.98%
AU
$138.98 416.85%
US
$761.87 7.04%
CH